Session Details

S018 Nail Symposium

Fri, Mar 7, 1:00 PM - 4:00 PM
Valencia Ballroom D
3 CME Available Symposium
View Map

DESCRIPTION

This session provides the most comprehensive up-to-date information on diagnosis and treatment of major nail disorders. Recognized experts from around the world will discuss the most current scientific evidence regarding onychomycosis, nail unit psoriasis, nail unit lichen planus, nail unit squamous cell carcinoma, nail unit melanoma, nail disorders in skin of color patients, self-induced nail disorders, onychoscopy, as well as others.

LEARNING OBJECTIVES

1.

Describe the most up to date therapy for patients with nail psoriasis.

2.

Manage patients with onychomycosis and terbinafine resistance.

3.

Describe the most up to date information on the diagnosis and treatment of nail unit melanoma.

SCHEDULE

1:00 PM

Addressing Onychomycosis Resistance

Aditya K. Gupta, MD, PhD, FAAD

1:10 PM

Integrating Novel Antifungals for Onychomycosis into Your Practice

Avner Shemer, MD, IFAAD

1:20 PM

State of the Art Treatment of Nail Unit Lichen Planus

Shari Lipner, MD, PhD, FAAD

1:30 PM

State of the Art Treatment of Nail Unit Psoriasis

Matilde Iorizzo, PhD, MD, IFAAD

1:40 PM

Diagnostic considerations and management of periungual warts

Kendall Billick, MD, FAAD

1:50 PM

Non-Surgical Management of Ingrown Toenails

C. Ralph Daniel, MD, FAAD

2:00 PM

How can we use minoxidil to treat or improve nails?

Antonella Tosti, MD

2:10 PM

Questions and Answers

2:20 PM

Addressing Malalignment of the Nails in Children and Adults

Bertrand Richert, MD, PhD, IFAAD

2:30 PM

Advances in the Diagnosis and Treatment of Nail Unit Squamous Cell Carcinoma

Molly A. Hinshaw, MD, FAAD

2:40 PM

Advances in the Diagnosis and Treatment of Nail Unit Melanoma

Nilton Gioia Di Chiacchio, MD, PhD

2:50 PM

Update on Nail Disorders in Skin of Color

Brian William Morrison, MD, MSc, FAAD

3:00 PM

Recognizing and Treating Self-Induced Nail Disorders

Michela Starace, MD, PhD, IFAAD

3:10 PM

How to use Dermoscopy Most Effectively to Diagnose Nail Disorders

Bianca Maria Piraccini, MD, IFAAD

3:20 PM

Surgical tips on obtaining optimal nail specimens for nail neoplastic and inflammatory disorders

Jorge Ocampo-Garza, MD, IFAAD

3:30 PM

Advances in Nail Unit Histopathology that Impact Dermatology Clinical Practice

Beth S. Ruben, MD, FAAD

3:40 PM

Artificial Intelligence (AI) and the Diagnosis of Nail Disorders

Fatih Goktay, MD

3:50 PM

Questions and Answers

DIRECTOR

Adam Rubin, MD, FAAD

Adam Rubin, MD, FAAD

SPEAKERS

Kendall Billick, MD, FAAD

Kendall Billick, MD, FAAD

C. Ralph Daniel, MD, FAAD

C. Ralph Daniel, MD, FAAD

Nilton Gioia Di Chiacchio, MD, PhD

Nilton Gioia Di Chiacchio, MD, PhD

Fatih Goktay, MD

Fatih Goktay, MD

Aditya K. Gupta, MD, PhD, FAAD

Aditya K. Gupta, MD, PhD, FAAD

Molly A. Hinshaw, MD, FAAD

Molly A. Hinshaw, MD, FAAD

Matilde Iorizzo, PhD, MD, IFAAD

Matilde Iorizzo, PhD, MD, IFAAD

Shari Lipner, MD, PhD, FAAD

Shari Lipner, MD, PhD, FAAD

Brian William Morrison, MD, MSc, FAAD

Brian William Morrison, MD, MSc, FAAD

Jorge Ocampo-Garza, MD, IFAAD

Jorge Ocampo-Garza, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Bertrand Richert, MD, PhD, IFAAD

Bertrand Richert, MD, PhD, IFAAD

Beth S. Ruben, MD, FAAD

Beth S. Ruben, MD, FAAD

Avner Shemer, MD, IFAAD

Avner Shemer, MD, IFAAD

Michela Starace, MD, PhD, IFAAD

Michela Starace, MD, PhD, IFAAD

Antonella Tosti, MD

Antonella Tosti, MD

HANDOUTS

Login to view handouts

DISCLOSURES

Kendall Billick, MD, FAAD

No financial relationships exist with ineligible companies.

C. Ralph Daniel, MD, FAAD

Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Medimetriks Pharmaceuticals, Inc. – Advisory Board(Stock Options); Ortho Dermatologics – Advisory Board(Honoraria); Springer Science & Business Media – Other(Fees); Visiting Professor – Speaker(Honoraria);

Nilton Gioia Di Chiacchio, MD, PhD

No financial relationships exist with ineligible companies.

Fatih Goktay, MD

No financial relationships exist with ineligible companies.

Aditya K. Gupta, MD, PhD, FAAD

Bausch Health – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Emblation Limited – Investigator(Grants/Research Funding); Moberg Derma – Consultant(Fees); Ortho Dermatologics – Consultant(Fees);

Molly A. Hinshaw, MD, FAAD

BiaCure Therapies Inc – Founder(Stock);

Matilde Iorizzo, PhD, MD, IFAAD

Almirall – Speaker(Fees); Bailleul – Speaker(Fees); Janssen Pharmaceuticals, Inc – Other(Other Financial Benefit); Laboratoires Bailleul – Speaker(Fees); Leo Pharma – Advisory Board(Fees);

Shari Lipner, MD, PhD, FAAD

BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);

Brian William Morrison, MD, MSc, FAAD

No financial relationships exist with ineligible companies.

Jorge Ocampo-Garza, MD, IFAAD

No financial relationships exist with ineligible companies.

Bianca Maria Piraccini, MD, IFAAD

ISDIN – Consultant(Fees); L'Oréal France – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);

Bertrand Richert, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.

Beth S. Ruben, MD, FAAD

No financial relationships exist with ineligible companies.

Adam Rubin, MD, FAAD

New York University Langone Medical Center – Employee – Lab does not sell products(Salary);

Avner Shemer, MD, IFAAD

No financial relationships exist with ineligible companies.

Michela Starace, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.

Antonella Tosti, MD

Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);